{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:15:38Z","timestamp":1791411338254,"version":"4.3.3"},"reference-count":50,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["nanomedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.nano.2014.03.014","type":"journal-article","created":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T22:04:05Z","timestamp":1396044245000},"page":"1517-1527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":277,"title":["Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages"],"prefix":"10.1016","volume":"10","author":[{"given":"Fatemeh","family":"Momen-Heravi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashi","family":"Bala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence","family":"Bukong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyongyi","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2014.03.014_bb0005","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3389\/fphys.2012.00354","article-title":"Alternative methods for characterization of extracellular vesicles","volume":"3","author":"Momen-Heravi","year":"2012","journal-title":"Front Physiol"},{"key":"10.1016\/j.nano.2014.03.014_bb0010","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrd3978","article-title":"Extracellular vesicles: biology and emerging therapeutic opportunities","volume":"12","author":"EL Andaloussi","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.nano.2014.03.014_bb0015","doi-asserted-by":"crossref","first-page":"e1001450","DOI":"10.1371\/journal.pbio.1001450","article-title":"Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation","volume":"10","author":"Kalra","year":"2012","journal-title":"PLoS Biol"},{"key":"10.1016\/j.nano.2014.03.014_bb0020","doi-asserted-by":"crossref","DOI":"10.4172\/jpb.10000e10","article-title":"Extracellular microvesicles: the need for internationally recognised nomenclature and stringent purification criteria","volume":"5","author":"Simpson","year":"2012","journal-title":"J Proteomics Bioinform"},{"key":"10.1016\/j.nano.2014.03.014_bb0025","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1586\/14737159.2014.893828","article-title":"Emerging technologies in extracellular vesicle-based molecular diagnostics","volume":"14","author":"Jia","year":"2014","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.nano.2014.03.014_bb0030","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fphys.2012.00162","article-title":"Impact of biofluid viscosity on size and sedimentation efficiency of the isolated microvesicles","volume":"3","author":"Momen-Heravi","year":"2012","journal-title":"Front Physiol"},{"key":"10.1016\/j.nano.2014.03.014_bb0035","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nm.2753","article-title":"Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET","volume":"18","author":"Peinado","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.nano.2014.03.014_bb0040","doi-asserted-by":"crossref","first-page":"E25","DOI":"10.1684\/bdc.2010.1294","article-title":"Mechanisms of tumor escape from the immune system: adenosine-producing Treg, exosomes and tumor-associated TLRs","volume":"98","author":"Whiteside","year":"2011","journal-title":"Bull Cancer"},{"key":"10.1016\/j.nano.2014.03.014_bb0045","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1593\/neo.13786","article-title":"Host matrix modulation by tumor exosomes promotes motility and invasiveness","volume":"15","author":"Mu","year":"2013","journal-title":"Neoplasia"},{"key":"10.1016\/j.nano.2014.03.014_bb0050","doi-asserted-by":"crossref","first-page":"13109","DOI":"10.1073\/pnas.1221899110","article-title":"Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells","volume":"110","author":"Ramakrishnaiah","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nano.2014.03.014_bb0055","doi-asserted-by":"crossref","first-page":"e1000740","DOI":"10.1371\/journal.ppat.1000740","article-title":"HIV and mature dendritic cells: Trojan exosomes riding the Trojan horse?","volume":"6","author":"Izquierdo-Useros","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.nano.2014.03.014_bb0060","first-page":"1525","article-title":"Exosome mimetics: a novel class of drug delivery systems","volume":"7","author":"Kooijmans","year":"2012","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2014.03.014_bb0065","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/wnan.1174","article-title":"A systematic approach to exosome-based translational nanomedicine","volume":"4","author":"Hood","year":"2012","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"10.1016\/j.nano.2014.03.014_bb0070","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.nano.2014.03.014_bb0075","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1093\/nar\/gks463","article-title":"Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes","volume":"40","author":"Wahlgren","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.nano.2014.03.014_bb0080","first-page":"1","article-title":"Therapeutic uses of exosomes","volume":"1","author":"Suntres","year":"2013","journal-title":"Exosomes Microvesicles"},{"key":"10.1016\/j.nano.2014.03.014_bb0085","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/mt.2011.164","article-title":"Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain","volume":"19","author":"Zhuang","year":"2011","journal-title":"Mol Ther"},{"key":"10.1016\/j.nano.2014.03.014_bb0090","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/mt.2013.55","article-title":"Liposome delivery of microRNA-145 to mesenchymal stem cells leads to immunological off-target effects mediated by RIG-I","volume":"21","author":"Karlsen","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.nano.2014.03.014_bb0095","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3390\/ph6050659","article-title":"FedExosomes: Engineering Therapeutic Biological Nanoparticles that Truly Deliver","volume":"6","author":"Marcus","year":"2013","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.nano.2014.03.014_bb0100","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1074\/jbc.M110.145870","article-title":"Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor alpha (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease","volume":"286","author":"Bala","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nano.2014.03.014_bb0105","doi-asserted-by":"crossref","first-page":"R194","DOI":"10.1186\/ar4384","article-title":"Adipokines, inflammation, insulin resistance, and carotid atherosclerosis in patients with rheumatoid arthritis","volume":"15","author":"Kang","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.nano.2014.03.014_bb0110","doi-asserted-by":"crossref","first-page":"835465","DOI":"10.1155\/2013\/835465","article-title":"The Relationship between Carotid Atherosclerosis, Inflammatory Cytokines, and Oxidative Stress in Middle-Aged and Elderly Hemodialysis Patients","volume":"2013","author":"Ren","year":"2013","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.nano.2014.03.014_bb0115","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/nrc3613","article-title":"Immunity, inflammation and cancer: a leading role for adenosine","volume":"13","author":"Antonioli","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.nano.2014.03.014_bb0120","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jconrel.2007.12.011","article-title":"Efficient drug targeting to rat alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for treatment of respiratory intracellular parasitic infections","volume":"127","author":"Chono","year":"2008","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2014.03.014_bb0130","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1086\/314929","article-title":"Synergistic effect of interferon-gamma and mannosylated liposome-incorporated doxorubicin in the therapy of experimental visceral leishmaniasis","volume":"180","author":"Kole","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.nano.2014.03.014_bb0135","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/ijc.1201","article-title":"Growth inhibition of human mammary carcinoma by liposomal hexadecylphosphocholine: participation of activated macrophages in the antitumor mechanism","volume":"92","author":"Eue","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.nano.2014.03.014_bb0140","doi-asserted-by":"crossref","first-page":"727241","DOI":"10.1155\/2011\/727241","article-title":"Targeted liposomal drug delivery to monocytes and macrophages","volume":"2011","author":"Kelly","year":"2011","journal-title":"J Drug Deliv"},{"key":"10.1016\/j.nano.2014.03.014_bb0145","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0378-5173(97)00411-0","article-title":"The macrophage as target or obstacle in liposome-based targeting strategies","volume":"162","author":"van Rooijen","year":"1998","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2014.03.014_bb0150","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1189\/jlb.72.3.417","article-title":"Macrophages in gene therapy: cellular delivery vehicles and in vivo targets","volume":"72","author":"Burke","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.nano.2014.03.014_bb0155","doi-asserted-by":"crossref","first-page":"8146","DOI":"10.4049\/jimmunol.180.12.8146","article-title":"Induction of exosome release in primary B cells stimulated via CD40 and the IL-4 receptor","volume":"180","author":"Saunderson","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2014.03.014_bb0160","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jconrel.2013.08.014","article-title":"Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles","volume":"172","author":"Kooijmans","year":"2013","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2014.03.014_bb0165","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1758-907X-1-10","article-title":"Specificity and functionality of microRNA inhibitors","volume":"1","author":"Robertson","year":"2010","journal-title":"Silence"},{"key":"10.1016\/j.nano.2014.03.014_bb0170","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nrc2966","article-title":"RNA interference in the clinic: challenges and future directions","volume":"11","author":"Pecot","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.nano.2014.03.014_bb0175","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1158\/0008-5472.CAN-09-4250","article-title":"MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene","volume":"70","author":"Jiang","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.nano.2014.03.014_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0039.2005.00532.x","article-title":"SOCS1: a potent and multifaceted regulator of cytokines and cell-mediated inflammation","volume":"67","author":"Davey","year":"2006","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.nano.2014.03.014_bb0185","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.nano.2014.03.014_bb0190","first-page":"2","article-title":"Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes","volume":"12","author":"Crescitelli","year":"2013","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.nano.2014.03.014_bb0195","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood-2011-02-338004","article-title":"Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes","volume":"119","author":"Montecalvo","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.nano.2014.03.014_bb0200","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/mt.2009.41","article-title":"Biological gene delivery vehicles: Beyond viral vectors","volume":"17","author":"Seow","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.nano.2014.03.014_bb0205","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/eji.200737694","article-title":"B cell activation regulates exosomal HLA production","volume":"38","author":"Arita","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.nano.2014.03.014_bb0210","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1615\/CritRevImmunol.v29.i3.20","article-title":"Exosome release by primary B cells","volume":"29","author":"McLellan","year":"2009","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.nano.2014.03.014_bb0215","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1038\/sj.emboj.7601842","article-title":"T cell-induced secretion of MHC class II-peptide complexes on B cell exosomes","volume":"26","author":"Muntasell","year":"2007","journal-title":"EMBO J"},{"key":"10.1016\/j.nano.2014.03.014_bb0220","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/intimm\/7.8.1243","article-title":"Long-term cultured CD40-activated B lymphocytes differentiate into plasma cells in response to IL-10 but not IL-4","volume":"7","author":"Rousset","year":"1995","journal-title":"Int Immunol"},{"key":"10.1016\/j.nano.2014.03.014_bb0225","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1172\/JCI119822","article-title":"CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy","volume":"100","author":"Schultze","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nano.2014.03.014_bb0230","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.cyto.2013.09.011","article-title":"Autocrine and paracrine modulation of microRNA-155 expression by globular adiponectin in RAW 264.7 macrophages: Involvement of MAPK\/NF-\u03baB pathway","volume":"64","author":"Subedi","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.nano.2014.03.014_bb0235","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1167\/iovs.13-11937","article-title":"STAT3 activates miR-155 in Th17 cells and acts in concert to promote experimental autoimmune uveitis","volume":"54","author":"Escobar","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.nano.2014.03.014_bb0240","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1515\/hsz-2013-0141","article-title":"Current methods for the isolation of extracellular vesicles","volume":"394","author":"Momen-Heravi","year":"2013","journal-title":"Biol Chem"},{"key":"10.1016\/j.nano.2014.03.014_bb0245","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.chembiol.2011.12.008","article-title":"RNA-based therapeutics: current progress and future prospects","volume":"19","author":"Burnett","year":"2012","journal-title":"Chem Biol"},{"key":"10.1016\/j.nano.2014.03.014_bb0250","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1021\/mp2006483","article-title":"Synthetic microRNA cassette dosing: pharmacokinetics, tissue distribution and bioactivity","volume":"9","author":"Wang","year":"2012","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nano.2014.03.014_bb0255","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jbiotec.2013.03.013","article-title":"Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection","volume":"165","author":"Takahashi","year":"2013","journal-title":"J Biotechnol"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963414001324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963414001324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T12:53:06Z","timestamp":1689079986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963414001324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1549963414001324"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2014.03.014","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2014.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}